Company: RENEF
Filing Date: 2025-10-20
Form Type: DEF 14A
Source: 0001104659-25-100857
Chunk: 59

Company: Cartesian Growth Corp II
Filing Date: 2025-10-20
Form: DEF 14A
Chunk 59
---
 on the amounts held in the Trust Account as of October 17, 2025; (b) would represent in writing that such public shares will not be voted in favor of approving the Extension; and (c) would
waive in writing any redemption rights with respect to the public shares so purchased.

<div align='center'>30</div>

To the extent any such purchases
by the Sponsor, the Company’s directors, officers, advisors or any of their respective affiliates are made in situations in which
the tender offer rules restrictions on purchases apply, the Company will disclose in a Current Report on Form 8-K prior to the Extraordinary
General Meeting the following: (i) the number of public shares purchased outside of the redemption offer, along with the purchase price(s)
for such public shares; (ii) the purpose of any such purchases; (iii) the impact, if any, of the purchases on the likelihood that the
Extension will be approved; (iv) the identities of the securityholders who sold to the Sponsor, the Company’s directors, officers,
advisors or any of their respective affiliates (if not purchased on the open market) or the nature of the securityholders (e.g., 5% security
holders) who sold such public shares; and (v) the number of Ordinary Shares for which the Company has received redemption requests pursuant
to its redemption offer.

The purpose of such share
purchases and other transactions would be to increase the likelihood of otherwise limiting the number of public shares electing to redeem.

If such transactions are
effected, the consequence could be to cause the Extension to be effectuated in circumstances where such effectuation could not otherwise
occur. Consistent with SEC guidance, purchases of shares by the persons described above would not be permitted to be voted for the Extension
at the Extraordinary General Meeting and could decrease the chances that the Extension would be approved. In addition, if such purchases
are made, the public “float” of our securities and the number of beneficial holders of our securities may be reduced, possibly
making it difficult to maintain or obtain the quotation, listing or trading of our securities on a national securities exchange.

Interests of the Sponsor and the Company’s Directors and Officers

When you consider the recommendation
of the Board, you should keep in mind that the Sponsor and the Company’s officers and directors have interests that may be different
from, or in addition to, your interests as a shareholder. These interests include, among other things:

|